111, Inc. (YI): Cost of Revenue

Annual figures by period end, from SEC filings.

11.83B CNY
Year ended 2025-12-31
-2.3%
3-year compound annual growth
+8.6%
5-year compound annual growth
14.10B CNY2017-12-31: 55.88M CNY2018-12-31: 73.93M CNY2019-12-31: 3.79B CNY2020-12-31: 7.84B CNY2021-12-31: 11.80B CNY2022-12-31: 12.68B CNY2023-12-31: 14.10B CNY2024-12-31: 13.57B CNY2025-12-31: 11.83B CNY11.83B CNY
2017-12-31 Cost of Revenue (CNY) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-3111.83B CNY-12.8%2026-04-30, From 2025-01-01
2024-12-3113.57B CNY-3.7%2026-04-30, From 2024-01-01
2023-12-3114.10B CNY+11.2%2026-04-30, From 2023-01-01
2022-12-3112.68B CNY+7.4%2025-08-29, From 2022-01-01
2021-12-3111.80B CNY+50.6%2024-05-14, From 2021-01-01
2020-12-317.84B CNY+107.0%2023-04-28, From 2020-01-01
2019-12-313.79B CNYn/m2022-04-29, From 2019-01-01
2018-12-3173.93M CNY+32.3%2021-04-30, From 2018-01-01
2017-12-3155.88M CNYn/a2020-04-16, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
111, Inc. (YI)2025-12-3111.83B CNY-12.8%
Baozun Inc. (BZUN)2025-12-312.58B CNY+4.1%
Here Group Ltd (HERE)2025-06-30503.73M CNY-8.5%
Boqii Holding Ltd (BQ)2026-03-31310.03M CNY-15.8%
Pomdoctor Ltd (POM)2025-12-31347.63M CNY+17.9%
Yunji Inc. (YJ)2025-12-31176.22M CNY-16.6%
JD.com, Inc. (JD)2025-12-311.10T CNY+12.7%

Compare YI, BZUN, HERE, BQ side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗